Inventor · disambiguated record
Neil J. Hayward
Also filed as: HAYWARD NEIL · HAYWARD NEIL J
13 granted patents·13 pending applications·352 citations·filing 1996–2024
92Inventor score
Files withEXITHERA PHARMACEUTICALS INC11PRAECIS PHARM INC5EXLTHERA PHARMACEUTICALS INC3NG HOWARD2HAYWARD NEIL J1
Top patents by PatentIndex Score
26 records- 0192US6303567B1Modulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 1996·Granted Oct 16, 2001·142 cites·135 claims
- 0292US5985242AModulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 1997·Granted Nov 16, 1999·120 cites·19 claims
- 0389US12084414B2Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2021·Granted Sep 10, 2024·1 cites·13 claims
- 0489US11198673B2Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2019·Granted Dec 14, 2021·3 cites·9 claims
- 0587US9499532B2Therapeutic compounds and compositionsEXLTHERA PHARMACEUTICALS INC·Filed 2015·Granted Nov 22, 2016·7 cites·22 claims
- 0686US10259785B2Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2018·Granted Apr 16, 2019·4 cites·10 claims
- 0786US8163761B2Methods and compositions for treating disordersNG HOWARD·Filed 2008·Granted Apr 24, 2012·14 cites·5 claims
- 0885US6689752B2Modulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 2001·Granted Feb 10, 2004·17 cites·21 claims
- 0985US2025214931A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1084US9994521B2Therapeutic compounds and compositionsEXLTHERA PHARMACEUTICALS INC·Filed 2016·Granted Jun 12, 2018·4 cites·18 claims
- 1184US6277826B1Modulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 1999·Granted Aug 21, 2001·36 cites·11 claims
- 1279US7175828B2Modulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 2003·Granted Feb 13, 2007·4 cites·13 claims
- 1369US12152014B2Therapeutic compounds and compositionsEXLTHERA PHARMACEUTICALS INC·Filed 2023·Granted Nov 26, 2024·0 cites·18 claims
- 1469US2023270731A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1565US2021361634A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1662US2012046305A1Methods and compositions for treating respiratory disordersMORAN MAGDALENE M·Filed 2009·Application pending·0 cites
- 1762US2023218594A1Therapeutic compounds, compositions, and methods of use thereofEXITHERA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1859US11691962B2Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2020·Granted Jul 4, 2023·0 cites·14 claims
- 1955US2007248996A1Modulators of beta-amyloid peptide aggregation comprising D-amino acidsPARAECIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2052US2018133170A1Methods and compositions for treating disordersHYDRA BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 2152US2005288222A1Methods for enhancing the bioavailability of a drugHAYWARD NEIL J·Filed 2004·Application pending·0 cites
- 2249US2021253550A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2349US2021261524A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2448US2013059869A1Methods and compositions for treating disordersNG HOWARD·Filed 2012·Application pending·0 cites
- 2545US2002142950A1Methods for enhancing the bioavailability of a drugFiled 2001·Application pending·0 cites
- 2638US2019315711A1Therapeutic compounds and compositionsEXITHERA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →